280P Intracranial activity of trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients with active brain metastases: Results from the first stage of the phase II TUXEDO-1 trial

https://doi.org/10.1016/j.annonc.2021.08.563Get rights and content
Under an Elsevier user license
open archive

Cited by (0)